Professor Arshad Majid
Professor of Cerebrovascular Neurology
Sheffield Institute for Translational Neuroscience
University of Sheffield
385a Glossop Road
Sheffield
S10 2HQ
Telephone: +44 (0)114 2222249
Fax: +44 (0)114 2222290
E-mail: arshad.majid@sheffield.ac.uk
Secretary: Rebecca Brown
Telephone: +44 (0)114 2222261
Email: rebecca.brown@sheffield.ac.uk
Biography
Professor Arshad Majid graduated in Medicine from the University of Glasgow, Scotland. After obtaining Membership of the Royal College of Physicians (MRCP) he moved to the USA where he did further training in Neurology at the University of Pennsylvania and Fellowship training in Stroke Research at Washington University in St. Louis. Arshad did additional Fellowship training in Endovascular Surgical Neuroradiology at the Medical College of Wisconsin.
Professor Majid has published extensively in high impact international peer-reviewed journals, and presented at national and international meetings. After finishing his training, Professor Majid served as the founding Director of the Division of Cerebrovascular Diseases at Michigan State University and was the founding Medical Director of the William and Claire Dart Stroke Center at Sparrow Health System. His research has been funded by the NIH, the American Heart Association, MRC (UK), NIHR (UK) and industry. He joined the University of Sheffield and Royal Hallamshire Hospital in August 2013 as Professor of Cerebrovascular Neurology.
Research Interests
Professor Majid's focus is translational cerebrovascular disease research. The models that are used in his research include both in vitro models (cell culture) and in vivo models (focal ischaemia and global ischaemia). He is interested in understanding the pathogenesis of cerebrovascular diseases with the intention of developing new treatment and brain repair strategies. To this end, his lab has been successful in developing two novel treatments which are undergoing further preclinical testing before they are taken to the clinic. He has a particular interest in ischaemic preconditioning, a fascinating phenomenon whereby animals exposed to sub-lethal or mild insults develop protection against subsequent severe insults. His lab has developed a mouse model of ischaemic preconditioning which is used extensively in their research efforts.
Other research interests and areas of collaboration include: large animal (ovine) models of stroke, clinical outcomes research, clinical trials, stroke epidemiology and translational bioengineering.
Doctoral Students
I would welcome enquiries from students interested in pursuing a doctorate in translational and clinical research. Several projects, preclinical (translational) and clinical are available
Post-Doctoral Scientists
Several preclinical and clinical projects are available
